{"schema_version":"secwatch.filing_event.v1","accession":"0001739104-25-000068","form_type":"8-K","ticker":"ELAN","cik":"0001739104","company_name":"Elanco Animal Health Inc","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.287091+00:00","generated_at":"2026-05-17T00:20:43.612427+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Elanco Q3 revenue $1.14B (+10% YoY); raises FY guidance, net leverage improves","bullets":["Q3 revenue $1,137M (+10% reported, +9% organic CC); adjusted EPS $0.19 vs $0.13 YoY (+46%).","Adjusted EBITDA $198M (+21%); net leverage ratio improved to 3.7x from 4.3x at FY 2024 end.","Raises FY 2025 revenue guidance to $4,645-4,670M and adjusted EPS to $0.91-0.94 (from $0.85-0.91).","Pet Health revenue $533M (+10%), driven by Credelio Quattro ($100M net sales in <8 months) and Zenrelia.","Refinanced $2.1B Term Loan B, extending maturities through 2032 and reducing interest cost."],"urls":{"canonical":"https://secwatch.observer/filing/0001739104-25-000068","json":"https://secwatch.observer/filing/0001739104-25-000068.json","markdown":"https://secwatch.observer/filing/0001739104-25-000068.md","text":"https://secwatch.observer/filing/0001739104-25-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739104/000173910425000068/0001739104-25-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739104/000173910425000068/elan-20251105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:20:43.612427+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}